Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
C4 Therapeutics and Calico Enter Strategic Partnership to Discover Novel Therapeutics
Friday, March 24, 2017C Therapeutics CT and Calico today announced a fiveyear collaboration to discover develop and commercialize therapies for treating diseases of aging including cancer Under the terms of the agreement the parties will leverage CTs expertise and capa...
BioLineRx Announces Acquisition of Agalimmune Ltd.
Friday, March 24, 2017BioLineRx Ltd a clinicalstage biopharmaceutical company focused on oncology and immunology announced today that it has acquired Agalimmune Ltd a private UKbased company with an innovative anticancer immunotherapy platform Acquisition consideration co...
Intec Pharma Initiates Phase I Trial of Accordion Pill for Cannabinoid Therapies
Thursday, March 23, 2017Intec Pharma Ltd a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology announces the initiation of a Phase I clinical trial of APCBDTHC its Accordion Pill platform with the...
Moleculin Receives Orphan Drug Designation for Annamycin
Thursday, March 23, 2017Moleculin Biotech Inc a preclinical pharmaceutical company focused on the development of anticancer drug candidates some of which are based on license agreements with The University of Texas System on behalf of the MD Anderson Cancer Center today ann...
Aprea Therapeutics Announces Research Collaboration with Memorial Sloan Kettering Cancer Center
Thursday, March 23, 2017Aprea Therapeutics a privately held clinical stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor protein p today announced a collaboration with Memorial Sloan Kettering Cancer Center to study the effec...
argenx announces collaboration with Broteio Pharma to develop therapeutic antibody
Wednesday, March 22, 2017argenx a clinicalstage biotechnology company developing a deep pipeline of differentiated antibodybased therapies for the treatment of severe autoimmune diseases and cancer today announced that it has entered into a new collaboration with Broteio Pha...
Pulmatrix Receives European Patent for its Inhaled Drug Delivery Technology
Wednesday, March 22, 2017Pulmatrix Inc a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases today announced that it has received a key patent from the European Union This new patent shows our continued ab...
Pierre Fabre and H-Immune Announce Strategic Research Partnership
Wednesday, March 22, 2017Pierre Fabre the second largest privately held pharmaceutical company in France and HImmune SAS an emerging biotechnology company focused on developing first in class immunotherapies for treatment of various cancers today announced that they have ent...
Novaliq GmbH Announces Licensing Agreement with AFT Pharmaceuticals
Tuesday, March 21, 2017Novaliq a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology today announced a strategic licensing agreement with AFT Pharmaceuticals AFT for th...
Mallinckrodt Completes Sale Of Its Intrathecal Therapy Business To Piramal Enterprises Limited
Tuesday, March 21, 2017Mallinckrodt plc a leading specialty pharmaceutical company announced today it has closed the sale of its Intrathecal Therapy business to Piramal Enterprises Limiteds subsidiary in the UK Piramal Critical Care for approximately million including fix...
